The global Neurological Disorder Drugs market was valued at 2036.41 Million USD in 2021 and will grow with a CAGR of 3.48% from 2021 to 2027.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson`s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period.Staggering increase in brain altering disorders such as Alzheimer`s, epilepsy, Parkinson`s, cerebrovascular, and sclerosis are promoting the pharmaceutical firms to tap into the significantly growing neurological disorder drugs market. This will potentially supplement the market growth in the coming years. Rise of several innovative drugs to manage these diseases will swell up the investments in the market. Increasing number of clinical trials are another reason boosting the market. Rise in geriatric population along with patients with strokes, migraines, and headaches leading to cerebrovascular diseases are likely to augment the growth of the market.

By Market Vendors:

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical

By Types:

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants

By Applications:

• Hospital
• Clinic

Key Indicators Analysed

• Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the markets competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
• Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
• Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
• Opportunities and Drivers: Identifying the Growing Demands and New Technology
• Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Table of content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Neurological Disorder Drugs Revenue

1.4 Market Analysis by Type

1.4.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Antipsychotic

1.4.3 Hypnotic & Sedative

1.4.4 Analgesics

1.4.5 Anticoagulants

1.5 Market by Application

1.5.1 Global Neurological Disorder Drugs Market Share by Application: 2022-2027

1.5.2 Hospital

1.5.3 Clinic

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Neurological Disorder Drugs Market

1.8.1 Global Neurological Disorder Drugs Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Neurological Disorder Drugs Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Neurological Disorder Drugs Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Neurological Disorder Drugs Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Neurological Disorder Drugs Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Neurological Disorder Drugs Sales Volume Market Share by Region (2016-2021)

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414


Similar Reports:

Global Neurological Disorder Drugs Market Research Report 2022

2022-2027 Global and Regional Neurological Disorder Drugs Industry Status and Prospects Professional Market Research Report Standard Version

2022-2027 Global and Regional Neurological Disorder Drugs Industry Status and Prospects Professional Market Research Report Standard Version

Neurological Disorder Drugs Market, Global Outlook and Forecast 2022-2028